A fire at four of JB Chemicals & Pharmaceuticals’ bulk drug manufacturing facilities earlier this month is likely to cause a ₹5-crore setback to its sales in 2018-19 (April-March). In a disclosure to the exchanges, the company said it needs 9-10 months to restore the factories and will invest ₹15-20 crore in new plant and machinery. The company has been allowed to demolish the damaged structure and is in the process of chalking out a plan to restore normalcy at the affected plants, the statement added. JB Chemicals will continue to manufacture some of the products made at the damaged plants in other facilities of the company in the area. It has eight facilities in Panoli. The company will also spend ₹2 crore in procuring bulk deals from external sources, which were earlier manufactured at the damaged facilities. The company, however, does not consider this impact as material keeping in view the size of its operations. “The insurance claim amount is not yet known, as the loss assessment is still not over,” the company said. Shares of JB Chemicals, which climbed to a high of ₹278.90 closed at ₹273, a gain of 1.1 per cent against the previous day’s close on the NSE.